Upgrade to SI Premium - Free Trial

Insys Therapeutics (INSY) Reaches Agreement in Principle to Settle DOJ Investigation

August 8, 2018 7:16 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Litigation Management Comments

Next Articles